Tenofovir Disoproxil Fumarate Safety for Women and their Infants
during Pregnancy and Breastfeeding: Systematic Review.
Mofenson LM, Baggaley RC, Mameletzis I.
AIDS. 2016 Nov 7.
Tenofovir exposure in utero and linear growth in HIV exposed,
uninfected infants: a prospective study.
M le Roux S, Jao J, Brittain K, . et al
2016 Oct 14.
Serum phosphate and creatinine levels in the first year of life
in infants born to HIV-positive mothers receiving tenofovir-based combination
regimens during pregnancy and prolonged breastfeeding in an option B+ programme
Floridia M, Liotta G, Andreotti M,
J Acquir Immune Defic Syndr. 2016 Aug 24
In-utero exposure to tenofovir is associated with impaired fetal
and infant growth: need for follow-up studies in combination antiretroviral
Denneman L, Cohen S, Godfried MH, et al
AIDS. 2016 Aug 24;30(13):2135-7
Prevention of mother-to-child transmission of hepatitis B virus: a phase III,
placebo-controlled, double-blind, randomized clinical trial to assess the
efficacy and safety of a short course of tenofovir disoproxil fumarate in women
with hepatitis B virus e-antigen.
Jourdain G, Ngo-Giang-Huong N, Cressey TR, et al
Infect Dis. 2016 Aug 9;16:393.
Detectable tenofovir levels in breastfeeding infants of mothers exposed to
Noguchi LM, Montgomery ET, Biggio JR,
Antimicrob Agents Chemother.
2016 Jul 11.
Concentrations of tenofovir, lamivudine and efavirenz in mothers and children
enrolled under the Option B-Plus approach in Malawi.
Palombi L, Pirillo MF, Marchei E, et al
J Antimicrob Chemother. 2015 Dec
Efficacy of tenofovir disoproxil fumarate to prevent vertical
transmission in mothers with lamivudine-resistant HBV.
Wang J, Liu J, Qi C, Yan T, et al
Antivir Ther. 2015 Jul 28
Lower Newborn Bone Mineral Content Associated with Maternal Use
of Tenofovir Disoproxil Fumarate During Pregnancy.
Siberry GK, Jacobson DL, Kalkwarf HJ,
Clin Infect Dis. 2015 Jun
9. pii: civ437
Pharmacokinetics of tenofovir during pregnancy and postpartum.
Best BM, Burchett S, Li H,
HIV Med. 2015 May 11.
Pharmacokinetics of Once versus Twice Daily
Darunavir In Pregnant HIV-Infected Women.
Stek A, Best BM, Wang J, et al
J Acquir Immune Defic Syndr.
2015 May 6
Assessing the implementation effectiveness and safety of 1% tenofovir gel
provision through family planning services in KwaZulu-Natal, South Africa: study
protocol for an open-label randomized controlled trial.
Mansoor LE, Karim QA, Mngadi KT, et al
Trials. 2014 Dec 19;15(1):496.
Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis
B Mono-Infected Pregnant Women.
Tsai PJ, Chang A, Yamada S, et al.
Dig Dis Sci. 2014 Jun 5.
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy
to prevent perinatal transmission of Hepatitis B Virus
Greenup AJ, Tan PK, Nguyen V, et al
J Hepatol. 2014 May 3.
Safety of tenofovir during pregnancy for the mother and fetus: A
Wang L, Kourtis AP, Ellington S,et al
Clin Infect Dis. 2013 Sep
Pharmacokinetics and Safety of Tenofovir in HIV-infected Women during Labor and
their Infants During the First Week of Life.
Mirochnick M, Taha T, Kreitchmann R, et al
J Acquir Immune Defic Syndr. 2013 Aug 23
Tenofovir useand pregnancy among women initiating HAART.
Maskew M, Westreich D,
Firnhaber C, Sanne I.
AIDS. 2012 Aug 28
Pregnancy and Infant Outcomes among HIV-Infected Women Taking
with and without Tenofovir in the DART Trial.
Gibb DM, Kizito H, Russell EC, et al
PLoS Med. 2012 May;9(5):e1001217
Safety of tenofovir use during pregnancy: early growth outcomes in
HIV-exposed uninfected infants.
Siberry GK, Williams PL, Mendez H,
AIDS. 2012 Feb 29